Pfizer Inc. is on track to shake billions of dollars’ worth of asbestos liabilities, as its long-defunct subsidiary Quigley Co. seeks federal court approval of a Chapter 11 plan already confirmed by a bankruptcy judge in New York. Read the Daily Bankruptcy Review article here.
[more]